Given their glucose-lowering effects, GLP-1s have become standard of care for type 2 diabetes, supplanting other medication classes such as sulfonylureas.2 In 2023, GLP-1s represented 63% of diabetes spend, up from 38% in 2020.2 While diabetes GLP-1s will continue to account for a greater portion of spend compared to obesity, costs related to GLP-1s prescribed for obesity are expected to grow at a faster rate over the next 3 years
The rationale is rooted in the complementary nature of their mechanisms: CJC-1295 provides a sustained "tide" of elevated GH raising the baseline from which the pituitary operates Ipamorelin adds sharp "waves" on top of that elevated baseline producing the pulsatile peaks the body uses for tissue repair, fat metabolism, and recovery This combination mimics the physiological pattern of GH secretion more closely than either peptide alone
Its also the foundation for Plastic Detox protocols like Chemzyme and the Plastic Detox Pak, so you can take action with precision
Its products focus on pulmonary arterial hypertension, including Remodulin, Tyvaso, and Orenitram, as well as advanced organ manufacturing and regenerative medicine technologies
Endothelial Nitric Oxide Synthase Regulation in Female Genital Tract Structures
